monobromobimane has been researched along with amifostine anhydrous in 1 studies
| Studies (monobromobimane) | Trials (monobromobimane) | Recent Studies (post-2010) (monobromobimane) | Studies (amifostine anhydrous) | Trials (amifostine anhydrous) | Recent Studies (post-2010) (amifostine anhydrous) |
|---|---|---|---|---|---|
| 199 | 1 | 42 | 1,636 | 249 | 247 |
| Protein | Taxonomy | monobromobimane (IC50) | amifostine anhydrous (IC50) |
|---|---|---|---|
| D(3) dopamine receptor | Homo sapiens (human) | 1.929 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, ML; Dubowy, RL; Fahey, RC; Newton, GL; Souid, AK | 1 |
1 other study(ies) available for monobromobimane and amifostine anhydrous
| Article | Year |
|---|---|
Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
Topics: Amifostine; Bridged Bicyclo Compounds; Child; Chromatography, High Pressure Liquid; Female; Fluorescent Dyes; Half-Life; Humans; Mercaptoethylamines; Prodrugs; Radiation-Protective Agents | 1998 |